<SEC-DOCUMENT>0001564590-18-006091.txt : 20180316
<SEC-HEADER>0001564590-18-006091.hdr.sgml : 20180316
<ACCEPTANCE-DATETIME>20180316170024
ACCESSION NUMBER:		0001564590-18-006091
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180313
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20180316
DATE AS OF CHANGE:		20180316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYTORI THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34375
		FILM NUMBER:		18696438

	BUSINESS ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8584580900

	MAIL ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cytx-8k_20180313.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
cytx-8k_20180313.htm
</title>
</head>
<!-- NG Converter v4.0.8.21 -->
<body>

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="pgbrk"></a>UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:16pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form 8-K</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Current Report&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date of Report<font style="font-weight:bold;">&#160;</font>(Date of earliest event reported):<font style="font-weight:bold;">&#160; March 13, 2018</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:180pt;"></td>
<td style="width:180pt;"></td>
<td style="width:180pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">001-34375</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">33-0827593</p></td>
</tr>
<tr style="height:30.95pt;">
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction of Incorporation)</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Commission File</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number)</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer Identification Number)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">3020 Callan Road, San Diego, California 92121</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, with zip code)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(858) 458-0900</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Registrant's telephone number, including area code)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">n/a</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="font-style:italic;">see</font> General Instruction A.2. below):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="hangingindent"></a><a name="hangingindent"></a>&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.7pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="&#116;&#97;&#98;&#50;"></a>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.7pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:539.9pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.6pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:539.9pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.6pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#070707;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:0.3pt;"> </font>check<font style="letter-spacing:-0.1pt;"> </font>mark whether<font style="letter-spacing:0.05pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>registrant<font style="letter-spacing:0.25pt;"> </font>is <font style="color:#171717;">a</font>n<font style="letter-spacing:0.1pt;"> </font>emerging<font style="letter-spacing:-0.1pt;"> </font>growth<font style="letter-spacing:0.15pt;"> </font>company<font style="letter-spacing:0.1pt;"> </font>as<font style="letter-spacing:-0.05pt;"> </font>defined<font style="letter-spacing:-0.1pt;"> </font>in as<font style="letter-spacing:-0.05pt;"> </font>defined<font style="letter-spacing:0.1pt;"> </font>in<font style="letter-spacing:-0.2pt;"> </font>Rule<font style="letter-spacing:0.05pt;"> </font>405<font style="letter-spacing:0.15pt;"> </font>of the<font style="letter-spacing:0.4pt;"> </font>Securities</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:7.22%;text-indent:0%;color:#070707;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Act<font style="letter-spacing:0.35pt;"> </font>of<font style="letter-spacing:1.05pt;"> </font>1933<font style="letter-spacing:-0.9pt;"> </font>(&#167;<font style="letter-spacing:-0.75pt;"> </font>230.405<font style="letter-spacing:0.3pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>this<font style="letter-spacing:0.15pt;"> </font>chapter)<font style="letter-spacing:0.05pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>Rule<font style="letter-spacing:1.1pt;"> </font>12b-2<font style="letter-spacing:-0.8pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:0.4pt;"> </font>Securities<font style="letter-spacing:-0.35pt;"> </font>Exchange<font style="letter-spacing:-0.15pt;"> </font>Act<font style="letter-spacing:0.35pt;"> </font>of<font style="letter-spacing:0.9pt;"> </font>1934<font style="letter-spacing:-0.7pt;"> </font>(&#167;<font style="letter-spacing:-0.75pt;"> </font>240.12b-2<font style="letter-spacing:0.25pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>this<font style="letter-spacing:0.15pt;"> </font>chapter). </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:7.22%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:7.22%;text-indent:0%;color:#070707;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging<font style="letter-spacing:0.2pt;"> </font>growth<font style="letter-spacing:0.15pt;"> </font>company<font style="letter-spacing:0.45pt;"> </font><font style="color:#000000;font-size:11pt;">&#9633;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#070707;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If<font style="letter-spacing:1.85pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">an</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.1pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">emerging</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.1pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">growth</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.05pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">company,</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.1pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">indi</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.05pt;">c</font><font style="color:#171717;font-size:10pt;font-family:Times New Roman;">a</font><font style="font-size:10pt;font-family:Times New Roman;">te</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.3pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">by</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.3pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">check</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.25pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">mark</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.35pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">if</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.15pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">the</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.15pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">registrant</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.05pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">has</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.2pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">elected</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.2pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">not to use the</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.2pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">e</font><font style="color:#171717;font-size:10pt;font-family:Times New Roman;">x</font><font style="font-size:10pt;font-family:Times New Roman;">tended</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.25pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">transition</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.15pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">period</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.4pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">for complying</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.25pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">with</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.4pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">any</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.4pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">new</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.3pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">or</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.2pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">re</font><font style="color:#171717;font-size:10pt;font-family:Times New Roman;">v</font><font style="font-size:10pt;font-family:Times New Roman;">ised</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.3pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">financial</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.05pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">accounting</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.05pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">standards</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.5pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">pro</font><font style="color:#171717;font-size:10pt;font-family:Times New Roman;">v</font><font style="font-size:10pt;font-family:Times New Roman;">ided</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.1pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">pursuant</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.15pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">to</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.5pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">Section</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.6pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">13(a)</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.9pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">of</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:-0.2pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">the</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.05pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">E</font><font style="color:#171717;font-size:10pt;font-family:Times New Roman;">x</font><font style="font-size:10pt;font-family:Times New Roman;">change</font><font style="font-size:10pt;font-family:Times New Roman;letter-spacing:0.05pt;"> </font><font style="font-size:10pt;font-family:Times New Roman;">Act.</font><font style="color:#000000;font-family:Times New Roman;font-size:11pt;"> &#9633;</font></p>
<p style="margin-top:12pt;line-height:10pt;margin-bottom:10pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </font></p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 8.01.<font style="margin-left:36pt;"></font>Other Events. </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><font style="color:#000000;">On March 13, 2018, Cytori Therapeutics, Inc. (the &#8220;Company&#8221; or &#8220;Cytori&#8221;) met with the U.S. Food and Drug Administration (&#8220;FDA&#8221;) to discuss the outcome of the STAR (Scleroderma Treatment with Celution Processed Adipose Derived Regenerative Cells) clinical trial and the Company&#8217;s plans for Habeo Cell Therapy.&nbsp;&nbsp;The STAR trial was a prospective, double-blind, randomized, multicenter, parallel-group Phase III pivotal study assessing the safety and efficacy of a single, subcutaneous administration of Habeo Cell Therapy, a Cytori Cell Therapy based candidate, into the fingers of patients with hand dysfunction due to scleroderma.&nbsp;&nbsp;At the meeting, the FDA provided verbal feedback that was generally consistent with the Company&#8217;s belief that a clinical trial focused on more severely affected diffuse systemic sclerosis patients could be an appropriate next step given the results of the STAR clinical trial.&nbsp;&nbsp;The Company intends to finalize meeting minutes and pursue additional dialogue with the FDA to clarify the parameters and key aspects of a potential follow-on clinical trial of Habeo Cell Therapy before making financial commitments to further pursue a follow-on clinical trial.</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cautionary Statement Regarding Forward-Looking Statements </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">This Current Report on Form 8-K includes forward-looking statements regarding events, trends and business prospects, which may affect Cytori&#8217;s future operating results and financial position. Such statements, including, but not limited to, statements regarding the Cytori&#8217;s plans to pursue dialogue with the FDA and possible future clinical trials of Habeo Cell Therapy that could cause Cytori&#8217;s actual results and financial position to differ materially. These risks and uncertainties include inherent uncertainties in the conduct of clinical studies and trials and the results of such trials (including risks that further studies may not support efficacy or safety of Cytori Cell Therapy), risks associated with clinical use of Cytori Cell Therapy in studies and trials not controlled by Cytori, risks to Cytori&#8217;s intellectual property portfolio, the risk that Habeo Cell Therapy may never be successfully commercialized or receive anticipated levels of commercial acceptance, risks associated with Cytori&#8217;s ability to raise additional funding that it may need to continue to pursue any follow-on clinical trials, and other risks described under the heading &#8220;Risk Factors&#8221; in Cytori&#8217;s Securities and Exchange Commission Filings on Form 10-K and Form 10-Q. Cytori assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date hereof.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><a name="part_1_2_2"></a><a name="item_1_47_1"></a><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><br /></p>
<p style="margin-top:12pt;line-height:10pt;margin-bottom:10pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</font></p>
<p style="margin-bottom:0pt;margin-top:13pt;text-indent:5%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:13pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:11.83%;width:75.83%;">
<tr>
<td style="width:43.33%;"></td>
<td style="width:32.5%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:&nbsp;&nbsp;March 16, 2018</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Tiago Girao</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tiago Girao</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VP Finance and Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:12pt;line-height:10pt;margin-bottom:10pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
